viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 2279
tüüp :
ajaleht
uurimisrühmad :
Houston - M.D.Anderson Cancer Center
Autor :
Kupiec T, Trusley C, Ben M, Trissel LA.
pealkiri :
Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration.
publikatsioon :
Am J Health-Syst Pharm ; 65, 18: 1735-1759. 2008
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Atropine sulfate
0.4 mg/ml
+
Palonosetron hydrochloride
50 µg/ml
+
Famotidine
2 mg/ml
+
Palonosetron hydrochloride
50 µg/ml
+
Heparin sodium
100 UI/ml
+
Palonosetron hydrochloride
50 µg/ml
+
Lidocaine hydrochloride
10 mg/ml
+
Palonosetron hydrochloride
50 µg/ml
+
Palonosetron hydrochloride
50 µg/ml
+
Atropine sulfate
0.4 mg/ml
+
50 µg/ml
+
Famotidine
2 mg/ml
+
50 µg/ml
+
Heparin sodium
100 UI/ml
+
50 µg/ml
+
Lidocaine hydrochloride
10 mg/ml
+
50 µg/ml
+
Potassium chloride
100 mEq/l
+
Potassium chloride
100 mEq/l
+
Palonosetron hydrochloride
50 µg/ml
+
25°C
Atropine sulfate
0,19 mg/ml
Palonosetron hydrochloride
25 µg/ml
4
25°C
Palonosetron hydrochloride
25 µg/ml
Heparin sodium
50 UI/ml
4
25°C
Palonosetron hydrochloride
25 µg/ml
Lidocaine hydrochloride
5,3 mg/ml
4
25°C
Potassium chloride
50 mEq/l
Palonosetron hydrochloride
25 µg/ml
4
25°C
Palonosetron hydrochloride
25 µg/ml
Famotidine
1 mg/ml
4
Mentions Légales
